Cargando…

Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients

OBJECTIVES: Vancomycin-resistant enterococcus infections impact mortality in oncology patients. Given the low rate of vancomycin-resistant enterococcus bacteremia, low virulence of vancomycin-resistant enterococcus, and advent of rapid diagnostic systems, vancomycin-resistant enterococcus-directed e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Snyder, Matthew, Pasikhova, Yanina, Baluch, Aliyah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477676/ https://www.ncbi.nlm.nih.gov/pubmed/34558349 http://dx.doi.org/10.1177/10732748211045593

Ejemplares similares

Neutropenic Fever
por: Baluch, Aliyah, et al.
Publicado: (2019)

Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
por: Snyder, Matthew, et al.
Publicado: (2017)

280. The Impact of a Revised Neutropenic Fever Guideline on Vancomycin-Resistant Enterococcus Rates in Pediatric Oncology Patients
por: Karandikar, Manjiree, et al.
Publicado: (2018)

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
por: Libuit, Jessica, et al.
Publicado: (2014)

Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
por: Lee, Dong-Gun, et al.
Publicado: (2011)

1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

Intestinal Coccidian Infections in Cancer Patients: A Case Series
por: Einhorn, Nathan, et al.
Publicado: (2023)

Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities
por: Davis, Elyse, et al.
Publicado: (2020)

Vancomycin Dosing in Neutropenic Patients
por: Haeseker, Michiel B., et al.
Publicado: (2014)

Disseminated Toxoplasmosis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report and Review of the Current Literature
por: Baluch, Aliyah, et al.
Publicado: (2022)

Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
por: Axelrad, Jordan E., et al.
Publicado: (2018)

483. Use of Terbinafine in Combination with Other Systemic Anti-fungal Agents As Treatment for Invasive Mold Infections. Experience from A National Cancer Institute Designated Cancer Center.
por: Ajayi, Eloho, et al.
Publicado: (2022)

A Comparative Study of Piperacillin-Tazobactam With and Without Vancomycin as Empirical Therapy for Febrile Neutropenic Patients With Solid Tumor Malignancies
por: Sirkhazi, Mansoor, et al.
Publicado: (2015)

Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients
por: Freitas, Maria Cecília S, et al.
Publicado: (2006)

P066: Risk factors of vancomycin-resistant enterococcus colonization in hemologic patients
por: Mioljevic, V, et al.
Publicado: (2013)

Vancomycin-resistant Enterococcus faecalis in Serbia
por: Stošović, Branka, et al.
Publicado: (2004)

Genomics of vancomycin-resistant Enterococcus faecium
por: Gorrie, Claire, et al.
Publicado: (2019)

Vancomycin Resistance in Enterococcus and Staphylococcus aureus
por: Li, Gen, et al.
Publicado: (2022)

Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review
por: de Bruin, Monique A, et al.
Publicado: (2007)

Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
por: Park, Sun Hee, et al.
Publicado: (2006)

Vancomycin-resistant Enterococcus faecium Empyema in an Asplenic Patient
por: Cotton, Matthew J, et al.
Publicado: (2018)

Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
por: Short, Elizabeth, et al.
Publicado: (2014)

Factors Associated with Vancomycin-Resistant Enterococcus Colonization in Patients Transferred to Emergency Departments in Korea
por: Kim, Hyun Soon, et al.
Publicado: (2018)

Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients
por: Chilambi, Gayatri Shankar, et al.
Publicado: (2020)

Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient
por: Goić-Barišić, Ivana, et al.
Publicado: (2020)

Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus
por: Isaac, Sandrine, et al.
Publicado: (2022)

2687. Extended Infusions of Piperacillin/Tazobactam vs. Cefepime for Empiric Treatment of Neutropenic Fever
por: Norman, Sarah, et al.
Publicado: (2019)

Gut Microbiota Predict Enterococcus Expansion but Not Vancomycin-Resistant Enterococcus Acquisition
por: Chanderraj, Rishi, et al.
Publicado: (2020)

Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation
por: van Niekerk, J. M., et al.
Publicado: (2022)

634. Incidence of vanC-Mediated Vancomycin-Resistant Enterococcus Bloodstream Infections at Children’s Hospital of Colorado and Implications for Empiric Enterococcal Therapy
por: Dodson, Daniel S, et al.
Publicado: (2019)

The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients
por: Alrstom, Ali, et al.
Publicado: (2021)

Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin
por: Comerlato, Carolina Baldisserotto, et al.
Publicado: (2013)

Virulence factors in vancomycin-resistant and vancomycin- susceptible Enterococcus faecalis from Brazil
por: Camargo, I. L. B. C., et al.
Publicado: (2008)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
por: Aktas, Gulseren
Publicado: (2020)

High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium
por: Guo, Yan, et al.
Publicado: (2017)

Vancomycin-resistant Enterococcus faecium Clone in Swine, Europe
por: Novais, Carla, et al.
Publicado: (2005)

Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium
por: Li, Qian, et al.
Publicado: (2022)

Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients
por: Rafey, Abdur, et al.
Publicado: (2022)

Draft Genome Sequence of a Vancomycin-Resistant and Vancomycin-Dependent Enterococcus faecium Isolate
por: Blaschitz, Marion, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qejlv2vhdjd4o222rm3km3fd92